title: Systematic review on the management of irritable bowel syndrome in North America.
authors.affiliation: Albert Einstein College of Medicine, Bronx, NY, USA.
authors.forename: Lawrence J
authors.initials: LJ
authors.lastname: Brandt
authors.forename: David
authors.initials: D
authors.lastname: Bjorkman
authors.forename: M Brian
authors.initials: MB
authors.lastname: Fennerty
authors.forename: G Richard
authors.initials: GR
authors.lastname: Locke
authors.forename: Kevin
authors.initials: K
authors.lastname: Olden
authors.forename: Walter
authors.initials: W
authors.lastname: Peterson
authors.forename: Eamonn
authors.initials: E
authors.lastname: Quigley
authors.forename: Philip
authors.initials: P
authors.lastname: Schoenfeld
authors.forename: Marvin
authors.initials: M
authors.lastname: Schuster
authors.forename: Nicholas
authors.initials: N
authors.lastname: Talley
mesh_terms: D000929:Antidepressive Agents, Tricyclic / Q000627:therapeutic use; D000930:Antidiarrheals / Q000627:therapeutic use; D001521:Behavior Therapy; D002243:Carbolines / Q000627:therapeutic use; D002400:Cathartics / Q000627:therapeutic use; D003109:Colonic Diseases, Functional / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology / Q000628:therapy; D003937:Diagnosis, Differential; D006801:Humans; D007211:Indoles / Q000627:therapeutic use; D008139:Loperamide / Q000627:therapeutic use; D009656:North America; D010276:Parasympatholytics / Q000627:therapeutic use; D016032:Randomized Controlled Trials as Topic / Q000592:standards; D012107:Research Design; D012702:Serotonin Antagonists / Q000627:therapeutic use; D017366:Serotonin Receptor Agonists / Q000627:therapeutic use; D012720:Severity of Illness Index; D016896:Treatment Outcome
chemical_list: D000929:Antidepressive Agents, Tricyclic; D000930:Antidiarrheals; D002243:Carbolines; D002400:Cathartics; D007211:Indoles; D010276:Parasympatholytics; D012702:Serotonin Antagonists; D017366:Serotonin Receptor Agonists; C090840:alosetron; C105050:tegaserod; D008139:Loperamide